Erratum to: Up-regulation of the mammalian target of rapamycin complex 1 subunit Raptor by aldosterone induces abnormal pulmonary artery smooth muscle cell survival patterns to promote pulmonary arterial hypertension (The FASEB Journal, (2016), 30, 7, (2511-2527), 10.1096/fj.201500042);Up-regulation of the mammalian target of rapamycin complex 1 subunit Raptor by aldosterone induces abnormal pulmonary artery smooth muscle cell survival patterns to promote pulmonary arterial hypertension

FASEB Journal

Volumn 30, Issue 7, 2016, Pages 2511-2527

  Aghamohammadzadeh, Reza ^a   Zhang, Ying Yi ^a   Stephens, Thomas E ^a   Arons, Elena ^a   Zaman, Paula ^a   Polach, Kevin J ^c   Matar, Majed ^c   Yung, Lai Ming ^a   Yu, Paul B ^a   Bowman, Frederick P ^a   Opotowsky, Alexander R ^a,d   Waxman, Aaron B ^b   Loscalzo, Joseph ^a   Leopold, Jane A ^a   Maron, Bradley A ^a,e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Celsion   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e NONE   (United States)

Author keywords

Kinase signaling; Pulmonary vascular disease disease; Vascular remodeling

Indexed keywords

ACTIN; ALDOSTERONE; EPLERENONE; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1 SUBUNIT RAPTOR; MONOCROTALINE; PROTEIN KINASE B; SMALL INTERFERING RNA; SPIRONOLACTONE; UNCLASSIFIED DRUG; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MULTIPROTEIN COMPLEX; RPTOR PROTEIN, HUMAN; S6 KINASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TARGET OF RAPAMYCIN KINASE;

ADULT; ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CELL PROLIFERATION ASSAY; CELL SURVIVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART CATHETERIZATION; HEMODYNAMICS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MIDDLE AGED; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY SMOOTH MUSCLE CELL; PULMONARY HYPERTENSION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; VASCULAR REMODELING; ANIMAL; APOPTOSIS; CELL CULTURE; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALDOSTERONE; ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; HYPERTENSION, PULMONARY; MALE; MULTIPROTEIN COMPLEXES; RATS; RATS, SPRAGUE-DAWLEY; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; UP-REGULATION;

EID: 84978062961     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.202400052     Document Type: Erratum

References (46)

1. Marsboom,G.,Toth,P.T.,Ryan,J.J.,Hong,Z.,Wu,X.,Fang,Y.H., Thenappan,T.,Piao,L.,Zhang,H.J.,Pogoriler,J.,Chen,Y.,Morrow, E.,Weir,E.K.,Rehman,J.,andArcher,S.L.(2012)Dynamin-related protein 1-mediated mitochondrial mitotic fission permits hyperproliferation of vascular smooth muscle cells and offers a novel therapeutic target in pulmonary hypertension. Circ. Res. 110, 1484-1497
2. Taraseviciene-Stewart, L., Kasahara, Y., Alger, L., Hirth, P., Mc Mahon, G., Waltenberger, J., Voelkel, N. F., and Tuder, R. M. (2001) Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J. 15,427-438
3. Humbert, M., Sitbon, O., Chaouat, A., Bertocchi, M., Habib, G., Gressin, V., Yaici, A., Weitzenblum, E., Cordier, J. F., Chabot, F., Dromer, C., Pison, C., Reynaud-Gaubert, M., Haloun, A., Laurent, M., Hachulla, E., and Simonneau, G. (2006) Pulmonary arterial hypertension in France: results from a national registry. Am. J. Respir. Crit. Care Med. 173, 1023-1030
4. Bockmeyer, C. L., Maegel, L., Janciauskiene, S., Rische, J., Lehmann, U., Maus, U. A., Nickel, N., Haverich, A., Hoeper, M. M., Golpon, H. A., Kreipe, H., Laenger, F., and Jonigk, D. (2012) Plexiform vasculopathy of severe pulmonary arterial hypertension and microRNA expression. J. Heart Lung Transplant. 31, 764-772
5. Jia, G., Aroor, A. R., Martinez-Lemus, L. A., and Sowers, J. R. (2014) Overnutrition, mTOR signaling, and cardiovascular diseases. Am. J. Physiol. Regul. Integr. Comp. Physiol. 307, R1198-R1206
6. Goncharov, D. A., Kudryashova, T. V., Ziai, H., Ihida-Stansbury, K., DeLisser, H., Krymskaya, V. P., Tuder, R. M., Kawut, S. M., and Goncharova, E. A. (2014) Mammalian target of rapamycin complex 2 (mTORC2) coordinates pulmonary artery smooth muscle cell metabolism, proliferation, and survival in pulmonary arterial hypertension. Circulation 129, 864-874
7. Krymskaya, V.P., Snow, J., Ceasarone, G., Khavin, I., Goncharov, D.A., Lim, P.N., Veasey, S.C., Ihidia-Stansbury, K., Jones, P.L., and Goncharova, E.A. (2011) mTOR is required for pulmonary artery vascular smooth muscle cell proliferation under chronic hypoxia. FASEB J. 25,1922-1933
8. Sengupta, S., Peterson, T. R., and Sabatini, D. M. (2010) Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol. Cell 40,310-322
9. Maron, B. A., Opotowsky, A. R., Landzberg, M. J., Loscalzo, J., Waxman, A. B., and Leopold, J. A. (2013) Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure: a pilot study. Eur. J. Heart Fail. 15, 277-283
10. Maron, B. A., Zhang, Y.-Y., White, K., Chan, S. Y., Handy, D. E., Mahoney, B. A., Loscalzo, J., and Leopold, J. A. (2012) Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension. Circulation 126,963-974
11. Preston, I. R., Sagliani, K. D., Warburton, R. R., Hill, N. S., Fanburg, B. L., and Jaffe, I. Z. (2013) Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension. Am.J.Physiol.Lung Cell. Mol. Physiol. 304,L678-L688
12. Maron, B. A., and Leopold, J. A. (2015) Emerging concepts in the molecular basis of pulmonary arterial hypertension: Part II: neurohormonal signaling contributes to the pulmonary vascular and right ventricular pathophenotype of pulmonary arterial hypertension. Circulation 131, 2079-2091
13. Su, H., Gu, Y., Li, F., Wang, Q., Huang, B., Jin, X., Ning, G., and Sun, F. (2013) The PI3K/AKT/mTOR signaling pathway is overactivated in primary aldosteronism. PLoS One 8, e62399
14. Wang, B., Ding, W., Zhang, M., Li, H., and Gu, Y. (2015) Rapamycin attenuates aldosterone-induced tubulointerstitial inflammation and fibrosis. Cell. Physiol. Biochem. 35, 116-125
15. Sakurabayashi-Kitade, S., Aoka, Y., Nagashima, H., Kasanuki, H., Hagiwara, N., and Kawana, M. (2009) Aldosterone blockade by Spironolactone improves the hypertensive vascular hypertrophy and remodeling in angiotensin II overproducing transgenic mice. Atherosclerosis 206,54-60
16. Lee, C.-C., Wang, C.-N., Lee, Y.-L., Tsai, Y.-R., and Liu, J.-J. (2015) High mobility group box 1 induced human lung myofibroblasts differentiation and enhanced migration by activation of MMP-9. PLoS One 10, e0116393
17. Wang, L., Guo, L. J., Liu, J., Wang, W., Yuan, J. X., Zhao, L., Wang, J., and Wang, C. (2013) MicroRNA expression profile of pulmonary artery smooth muscle cells and the effect of let-7d in chronic thromboembolic pulmonary hypertension. Pulm. Circ. 3, 654-664
18. Mill, C., Monk, B. A., Williams, H., Simmonds, S. J., Jeremy, J. Y., Johnson, J. L., and George, S. J. (2014) Wnt5a-induced Wnt1-inducible secreted protein-1 suppresses vascular smooth muscle cell apoptosis induced by oxidative stress. Arterioscler. Thromb. Vasc. Biol. 34, 2449-2456
19. McLendon, J. M., Joshi, S. R., Sparks, J., Matar, M., Fewell, J. G., Abe, K., Oka, M., McMurtry, I. F., and Gerthoffer, W. T. (2015) Lipid nanoparticle delivery of a microRNA-145 inhibitor improves experimental pulmonary hypertension. J. Control. Release 210, 67-75
20. White,K.,Lu,Y.,Annis,S.,Hale,A.E.,Chau,B.N.,Dahlman,J.E., Hemann, C., Opotowsky, A. R., Vargas, S. O., Rosas, I., Perrella, M.A.,Osorio,J.C.,Haley,K.J.,Graham,B.B.,Kumar,R.,Saggar, R.,Saggar,R.,Wallace,W.D.,Ross,D.J.,Khan,O.F.,Bader,A., Gochuico, B. R., Matar, M., Polach, K., Johannessen, N. M., Prosser, H. M., Anderson, D. G., Langer, R., Zweier, J. L., Bindoff, L. A., Systrom, D., Waxman, A. B., Jin, R. C., and Chan, S. Y. (2015) Genetic and hypoxic alterations of the microRNA-210-ISCU1/ 2 axis promote iron-sulfur deficiency and pulmonary hypertension. EMBO Mol. Med. 7, 695-713
21. Abe, K., Toba, M., Alzoubi, A., Ito, M., Fagan, K. A., Cool, C. D., Voelkel, N. F., McMurtry, I. F., and Oka, M. (2010) Formation of plexiform lesions in experimental severe pulmonary arterial hypertension. Circulation 121, 2747-2754
22. Maron, B. A., Oldham, W. M., Chan, S. Y., Vargas, S. O., Arons, E., Zhang, Y.-Y., Loscalzo, J., and Leopold, J. A. (2014) Upregulation of steroidogenic acute regulatory protein by hypoxia stimulates aldosterone synthesis in pulmonary artery endothelial cells to promote pulmonary vascular fibrosis. Circulation 130, 168-179
23. French, C. J., Spees, J. L., Zaman, A. K. M. T., Taatjes, D. J., and Sobel, B. E. (2009) The magnitude and temporal dependence of apoptosis early after myocardial ischemia with or without reperfusion. FASEB J. 23, 1177-1185
24. McMurtry, M. S., Bonnet, S., Wu, X., Dyck, J. R. B., Haromy, A., Hashimoto, K., and Michelakis, E. D. (2004) Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis. Circ. Res. 95, 830-840
25. Wang,W.,Liu,J.,Ma,A.,Miao,R.,Jin,Y.,Zhang,H.,Xu,K.,Wang,C., and Wang, J. (2014) mTORC1 is involved in hypoxia-induced pulmonary hypertension through the activation of Notch3. J. Cell Physiol. 229,2117-2125
26. Lee, J. W., Park, S., Takahashi, Y., and Wang, H. G. (2010) The association of AMPK with ULK1 regulates autophagy. PLoS One 5, e15394
27. Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., and Shaw, R. J. (2008) AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30, 214-226
28. Foster, K. G., and Fingar, D. C. (2010) Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony. J. Biol. Chem. 285, 14071-14077
29. Hei, Y. J., Pelech, S. L., Chen, X., Diamond, J., and McNeill, J. H. (1994) Purification and characterization of a novel ribosomal S6 kinase from skeletal muscle of insulin-treated rats. J. Biol. Chem. 269, 7816-7823
30. Pearson, R. B., Dennis, P. B., Han, J. W., Williamson, N. A., Kozma, S. C., Wettenhall, R. E., and Thomas, G. (1995) The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. EMBO J. 14, 5279-5287
31. Ranchoux, B., Antigny, F., Rucker-Martin, C., Hautefort, A., Péchoux, C., Bogaard,H. J., Dorfmüller, P., Remy, S., Lecerf, F., Planté, S., Chat, S., Fadel, E., Houssaini, A., Anegon, I., Adnot, S., Simonneau, G., Humbert, M., Cohen-Kaminsky, S., and Perros, F. (2015) Endothelialto-mesenchymal transition in pulmonary hypertension. Circulation 131, 1006-1018
32. Oshiro, N., Rapley, J., and Avruch, J. (2014) Amino acids activate mammalian target of rapamycin (mTOR) complex 1 without changing Rag GTPase guanyl nucleotide charging. J. Biol. Chem. 289, 2658-2674
33. Sancak, Y., Peterson, T. R., Shaul, Y. D., Lindquist, R. A., Thoreen, C. C., Bar-Peled, L., and Sabatini, D. M. (2008) The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320, 1496-1501
34. Thompson, A. M., Martin, K. A., and Rzucidlo, E. M. (2014) Resveratrol induces vascular smooth muscle cell differentiation through stimulation of SirT1 and AMPK. PLoS One 9, e85495
35. McMurtry, M. S., Archer, S. L., Altieri, D. C., Bonnet, S., Haromy, A., Harry, G., Bonnet, S., Puttagunta, L., and Michelakis, E. D. (2005) Gene therapy targeting survivin selectivity induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. J. Clin. Invest. 115, 1479-1491
36. Hansmann, G., Wagner, R. A., Schellong, S., Perez, V. A., Urashima, T., Wang, L., Sheikh, A. Y., Suen, R. S., Stewart, D. J., and Rabinovitch, M. (2007) Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation. Circulation 115,1275-1284
37. Duan, Y., Li, F., Tan, K., Liu, H., Li, Y., Liu, Y., Kong, X., Tang, Y., Wu, G., and Yin, Y. (2015) Key mediators of intracellular amino acids signalingtomTORC1activation.Amino Acids 47,857-867
38. Sherajee, S. J., Fujita, Y., Rafiq, K., Nakano, D., Mori, H., Masaki, T., Hara, T., Kohno, M., Nishiyama, A., and Hitomi, H. (2012) Aldosterone induces vascular insulin resistance by increasing insulin-like growth factor-1 receptor and hybrid receptor. Arterioscler. Thromb. Vasc. Biol. 32,257-263
39. Chen, X., Talati, M., Fessel, J.P., Hemnes, A.R., Gladson, S., Fench, J., Shay, S., Trammell, A., Phillips, J.A., Hamid, R., Cogan, J.D., Dawson, E.P., Womble, K.E., Hedges, L.K., Martinez, E.G., Wheeler, L.A., Majka, S.J., Lloyd, J.E., West, J., and Austin, E.D. (2016) Estrogen metabolite 16a-hydroxyestrone exacerbates bone morphogenetic protein receptor type II-associated pulmonary arterial hypertension through microRNA-29-mediated modulation of cellular metabolism. Circulation 133,82-97
40. Frump, A. L., Goss, K. N., Vayl, A., Albrecht, M., Fisher, A., Tursunova, R., Fierst, J., Whitson, J., Cucci, A. R., Brown, M. B., and Lahm, T. (2015) Estradiol improves right ventricular function in rats with severe angioproliferative pulmonary hypertension: effects of endogenous and exogenous sex hormones. Am.J.Physiol.LungCell. Mol. Physiol. 308, L873-L890
41. Wallace, E., Morrell, N. W., Yang, X. D., Long, L., Stevens, H., Nilsen, M.,Loughlin,L.,Mair,K.M.,Baker,A.H.,andMacLean,M.R.(2015) A sex-specific MicroRNA-96/5-hydroxytryptamine 1B axis influences development of pulmonary hypertension. Am. J. Respir. Crit. Care Med. 191,1432-1442
42. Kirsch,T.,Beese,M.,Wyss,K.,Klinge,U.,Haller,H.,Haubitz,M.,and Fiebeler, A. (2013) Aldosterone modulates endothelial permeability and endothelial nitric oxide synthase activity by rearrangement of the actin cytoskeleton. Hypertension 61,501-508
43. Li,L.,Wang,X.,Wang,L.,Qu,L.,Zhu,X.,Li,M.,Dang,X.,Li,P.,Gao, Y., Peng, Z., Pan, L., and Wan, L. (2015) Mammalian target of rapamycin overexpression antagonizes chronic hypoxia-triggered pulmonary arterial hypertension via the autophagic pathway. Int. J. Mol. Med. 36,316-322
44. Seyfarth, H.-J., Hammerschmidt, S., Halank, M., Neuhaus, P., and Wirtz, H. R. (2013) Everolimus in patients with severe pulmonary hypertension: a safety and efficacy pilot trial. Pulm. Circ. 3, 632-638
45. Manning, B. D., and Cantley, L. C. (2007) AKT/PKB signaling: navigating downstream. Cell 129, 1261-1274
46. Fattori, R., and Piva, T. (2003) Drug-eluting stents in vascular intervention. Lancet 361, 247-249